New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and how safe the medicine is over four years of use. The analyses – of a trial called Select, whose results showed last year […]
Tag: Wegovys
After Wegovy’s Approval to Treat Heart Disease, Novo Nordisk Continues to Make Moves
Diabetes and obesity care are two engines fueling the pharmaceutical industry right now. Novo Nordisk (NYSE: NVO) is at the forefront of these markets thanks to its red-hot blockbuster drugs Ozempic, Rybelsus, and Wegovy. 2024 has been a milestone year for Novo Nordisk, and the momentum doesn’t appear to be slowing down. Let’s dig into […]